Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:
-
Cowen 41st Annual Health Care Conference
Date: Monday, March 1st at 2:40 p.m. Eastern Time
-
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9th at 7:00 a.m. Eastern Time
-
Barclays Global Healthcare Conference
Date: Wednesday, March 10th at 10:55 a.m. Eastern Time
For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005058/en/
Sangamo Therapeutics Inc. Stock
Based on 12 Buy predictions and 12 Sell predictions the sentiment towards Sangamo Therapeutics Inc. is rather balanced.
With a target price of 3 € there is potential for a 480.83% increase which would mean more than doubling the current price of 0.52 € for Sangamo Therapeutics Inc..
